Directory → Organotropona funds → Cardiovascular funds → Corrector disturbance of cerebral circulation → Instenon
This page is translated automatically with a help of Google Translate

Instenon

See also Vinpocetine

Roman name

Instenon

The composition and the form of

Male Film-coated-1 tabl.etamivan-50 mggexobendina digidrohlorid-20 mgetofillin-60 megawatts blistere 10 pcs. ; Bundle in a cardboard 3 Blister.tabletki Film-coated, Fort-1 tabl.etamivan-100 mggexobendina digidrohlorid-60 mgetofillin-60 megawatts blistere 10 pcs. ; In the paper cartons 2 5 or 30 Blisterov.rastvor injection-2 mlatamivan-50 mggexobendina digidrohlorid-10 mgetofillin-100 megawatts ml to 2 ml; in the paper cartons five vials.

Pharmacokinetics

Research pharmacokinetics of the drug Instenon pending.

Farmakodinamika

Etamivan starts breathing and sosudodwigatelny Centre has expressed aguirutee impact on limbicescuu system and the formation retikuljarnuu barrel brain, which leads to an operation neural systems crust and podcorkov-stwolovh structures and, consequently, to regression neurological deficit and activation of heart. Gexobendin stabilizes the autoregulyation cerebral and cardiac disorders, moderate increases coronary and brain vessels increases the transport and disposal of glucose and oxygen brain cells, stimulates metabolism neironalny, activates anaerobnyy glikoliz and pentosny cycle, which facilitates the fusion and exchange neiromediatorov, restores sinapticescuu transfer. Etofillin more minutes of the heart, which increases perfuzing pressure receptacles edge of Ischemia, stimulates podcorkove education secondary brain centres - breathing, sosudodwigatelny, autonomic regulation, the kernel head nerves, primarily wandering.

Indications

Diseases of the brain and vascular age character; The lack of blood brain; Postinsultne condition; Dizziness caused by functional brain.

Pregnancy and lactation

Valid only on the strict condition.

Contraindications

Hypersensitivity, epileptiformnye syndromes (of a strong institution, convulsions, etc.), increased intracranial pressure (long headache, vomiting, impaired vision), haemorrhage.

Side-Effects

The rapid on / in a drop-AD minute short, unpleasant feelings in the heart, a small headache (phenomena are at the same time reducing the dose or termination of).

Specific guidance

In some cases, with the rapid on / in a drop may AD, and the single-screen shall be not less than 3 min.

Patient interaction

Do braking aggregation of platelets (through gexobendina) acetylsalicylic acid. Caffeine (in very high doses) may weaken the effect.

Precautions

During treatment advised to avoid the use of large quantities of coffee and tea. The on / in the application shall be permitted only slow drip introduction, in the case of / investments in a 1 ml 2 ml shall not be less than 3 minutes.

Storage conditions

List B. In the dark place at a temperature of 15-25 ° C

Shelf life

5 years

The registration

014738/03-2003

Indications for use

Preparation for the proposed application ishemicescom stroke (acute human blood brain), the residual phenomena post-stroke, discirkulatorna encephalopathy, traumatic encephalopathy, wegetososudistoi dystonia, and other cerebrovascular insufficiency (insufficient blood brain).

Dosing and Administration

Assign instenon inwards intravenously and intramuscularly.

Form of

Tablets containing 20 mg gexobendina, 50 etamivana mg and 60 mg etofillina; Forte tablets containing 60 mg gexobendina, 100 etamivana mg and 60 mg etofillina; In sealed ampoules containing 10 mg gexobendina, 50 etamivana mg and 100 mg etofillina.

All products of this group

0